Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK/CNS deal complete

This article was originally published in The Tan Sheet

Executive Summary

GlaxoSmithKline has completed its $566 million acquisition of Breathe Right and FiberChoice maker CNS, the firm announces Dec. 19. "The opportunity for growth through geographic expansion make[s] this an exciting prospect," GSK Consumer Healthcare President John Clarke said. FiberChoice is sold only in the U.S., but Breathe Right is sold in 26 countries including Hong Kong, Mexico, South Africa and Portugal, according to GSK. The acquisition should help CNS protect the intellectual property rights and market share of its Breathe Right brand, the firm said in a filing with the Securities & Exchange Commission (1"The Tan Sheet" Nov. 6, 2006, p. 3)...

You may also be interested in...



GSK Launches Breathe Right Kids, Cites Scrutiny Of Pediatric Cold Products

GlaxoSmithKline joins the list of manufacturers launching drug-free cough/cold remedies for children to meet growing demand in the wake of FDA's review of pediatric OTC drugs

GSK Merger Helps CNS Breathe Easier About Breathe Right Patent Expiration

CNS sees its proposed acquisition by Glaxo as an opportunity to protect the intellectual property rights and market share of its Breathe Right brand with the additional resources available to a larger company

3D Carbon Partners With Resolution Medical To Produce More Than 1 Million Nasal Swabs A Week

Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.

Topics

UsernamePublicRestriction

Register

PS100069

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel